Kronox Lab Sciences Limited IPO

Mainboard

Specialty Chemicals

Listed On: Jun 10, 2024 at ₹ 164.95(NSE)

₹ 14960 /110 Shares

Check Allotment

03 Jun, 2024

Open Date

05 Jun, 2024

Close Date

06 Jun, 2024

Allotment Date

10 Jun, 2024

Listing Date

Price Summary

Last Closing

143.10 (5.22%)

52 Week High

228.75

52 Week Low

130.30

Last Update

17-Dec-2025 3:30 PM

Kronox Lab Sciences Limited IPO Issue Details

Issue Price ₹129-136 per equity share
Face Value ₹10 Per Equity Share
Total Issue Size 95,70,000 shares(aggregating up to ₹130.15 crore)
Offer For Sale 95,70,000 shares(aggregating up to ₹130.15 crore)
Listing at BSE, NSE
List Price 164.95(NSE)
Listing Date 2024-06-10
Lead Manager Pantomath Capital Advisors Pvt Ltd
Registrar Kfin Technologies Limited

Market Lot Size

Investors can bid for a minimum of 110 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.

Application	Lots	Shares	Amount
Retail (min)	1	110	₹14,960
Retail(max)	13	1,430	₹1,94,480

Kronox Lab Sciences Limited IPO Reservation

Kronox Lab Sciences Limited IPO offers total 9,570,000 shares. Out of which 1,914,000 (20%) allocated to QIB, 1,435,500 (15%) allocated to NII,3,349,500 (35%) allocated to RII, NA (NA%) allocated to employees and 2,871,000 (30%) allocated to Anchor investors.

Investor Category	Shares Offered	Maximum Allottees
Anchor Investor Shares Offered	2,871,000 (30%)
QIB Shares Offered	1,914,000 (20%)
NII (HNI) Shares Offered	1,435,500 (15%)
bNII > ₹10L	957,000 (10%)
sNII < ₹10L	478,500 (5%)
Retail Shares Offered	3,349,500 (35%)
Total Shares Offered	9,570,000 (100%)

Kronox Lab Sciences Limited IPO Documents

DRHP

RHP

ANCHOR

Kronox Lab Sciences Limited IPO Details

Kronox Lab Sciences Limited IPO is a book-built issue of ₹130.15 crores, The total issue size is ₹130.15 crores. The IPO of Kronox Lab Sciences Limited is priced at ₹129-136 per equity share, which has a face value of ₹10 Per Equity Share each, IPO bidding starts from Jun 3, 2024 and ends on Jun 5, 2024. The allotment for Kronox Lab Sciences Limited IPO will be finalized on Jun 6, 2024. Kronox Lab Sciences Limited IPO will be listed on BSE, NSE, with a tentative listing date fixed as Jun 10, 2024. The company shall list its equity shares on the BSE, NSE. Kfin Technologies Limited is the registrar of the issue.

Retail investors can bid for a minimum of 110 shares, extendable to 14,960. The book-running lead manager for the IPO is/are Pantomath Capital Advisors Pvt Ltd.

The total issue ₹130.15 crore and having Offer for Sale (OFS) of 95,70,000 shares to mop up ₹130.15 crore.

The Kronox Lab Sciences Limited IPO sets its price band at 129-136 for each share. A single application for Kronox Lab Sciences Limited IPO must contain at least 110 shares. Sentiment investors need to invest a minimum of 110 through their retail account. For investors to prevent oversubscription issues, they should submit bids at the cutoff price, which estimates about ₹14,960

As on	QIB	NII bNII sNII	Retail	Total
Shares Offered / Reserved	4,785,000	1,435,500 957,000 478,500	3,349,500	6,699,000
Day 1 03-06-24 05:00 PM	1.11 x	19.97 15.93 x 28.05 x	13.00 x	11.10 x
Day 2 04-06-24 05:00 PM	3.39 x	52.94 45.18 x 68.47 x	24.55 x	24.59 x
Day 3 05-06-24 05:00 PM	89.03 x	301.92 322.26 x 261.23 x	54.23 x	117.25 x

Total No of Applications

15,28,029

Subscription on the basis of Applications

Retail:50.1x BHNI:60.6x SHNI:240.1x

Kronox Lab Sciences Limited Valuations

EPS Pre IPO ₹4.48/-

EPS Post IPO ₹5.56/-

P/E Pre IPO 30.37

P/E Post IPO 24.47

ROE 25.66%

ROCE 33.15%

RoNW 25.66%

PAT Margin 22.60

Price to Book Value 8.37

Kronox Lab Sciences Limited Company Financials

In Crs.

In Cr.

	31-Mar-23	31-Mar-22	31-Mar-21
Assets	54.03	56.79	37.65
Revenue	97.50	83.34	63.24
Profit After Tax	16.62	13.63	9.73
Net Worth	44.68	40.35	26.81
Reserves & Surplus	7.58	40.11	26.57

About Kronox Lab Sciences Limited Company

Kronox Lab Sciences Limited is a manufacturer of high-purity speciality fine chemicals for diverse end-user industries. The company's High Purity Specialty Fine Chemicals are used in various applications such as manufacturing APIs, pharmaceutical formulations, scientific research, nutraceuticals, biotech applications, agrochemical formulations, personal care products, metal refineries, and animal health products.

The company offers a wide range of over 185 products, including phosphate, sulphate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, gluconate, and others. These products are supplied to customers in India and more than 20 countries worldwide.

The company exports its products to countries such as United States, Argentina, Mexico, Australia, Egypt, Spain, Turkey, United Kingdom, Belgium, United Arab Emirates, China, among others.

The company has three manufacturing facilities in Vadodara, Gujarat, close to the seaports of Mundra, Kandla, Hazira, and Nhava Sheva. The facilities cover 17,454 sq. m. and have an installed capacity of 7,242 TPA as of December 31, 2023. Unit I/II holds FSSC 22000 (Version 5), ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 certifications. Additionally, some products manufactured at Unit I have obtained Kosher, Halal, GMP, and GLP certifications.

As of December 31, 2023, the company is conducting research and development on 122 products.

The company has served over 592 customers in the past three years. By December 31, 2023, 141 customers of the total, placed repeat orders.

As of December 31, 2023, the company employees 212 people at various levels.

Kronox Lab Sciences Limited - Promoter(s)

Jogindersingh Jaswal

Ketan Ramani

Pritesh Ramani

Pre Issue Share Holding : 99.98%

Post Issue Share Holding : 74.21%

Kronox Lab Sciences Limited IPO - Issue Objectives

Carry out the Offer for Sale of up to 95,70,000 Equity Shares by the Promoter Selling Shareholders

Achieve the benefits of listing the Equity Shares on the Stock Exchanges. Further, the Company expects that the proposed listing of the Equity Shares will enhance the visibility and brand image, provide liquidity to its existing Shareholders, and provide a public market for Equity Shares in India.

Kronox Lab Sciences Limited IPO - Anchor Investors

Kronox Lab Sciences raises over Rs 39 crore from anchor investors ahead of IPO.

Negen Undiscovered Value Fund is the biggest institutional investor among them, buying Rs 7.57 crore worth of shares, followed by Chanakya Opportunities Fund I and Minerva Emerging Opportunities Fund, which picked up Rs 7.48 crore worth of equity shares each.

Capri Global Capital, Moneywise Financial Services, and VPK Global Ventures Fund bought Rs 5.5 crore worth of shares each.

Kronox Lab Sciences Limited IPO - Peers Comparison

Company Name	EPS (Basic)	EPS (Diluted)	NAV (per share) (Rs)	P/E (x)	RoNW (%)	P/BV Ratio	Financial statements
Kronox Lab Sciences Limited	4.3	4.3	12.04	N/A	37.19	11.3	Consolidated
Tatva Chintan Pharma Chem Limited	19.45	19.45	220.07	57.57	8.84	5.09	Consolidated
Tanfac Industries Ltd.	56.27	56.27	184.74	39.15	30.46	11.92	Consolidated
Neogen Chemicals Ltd	18.94	18.94	182.9	77.55	10.36	8.03	Consolidated
Sigachi Industries Limited	1.42	1.42	8.73	46.64	16.22	7.57	Consolidated
DMCC Speciality Chemical Limited	2.78	2.78	79.49	116.57	3.5	4.08	Consolidated

Notes:

Current Market Price (CMP) is the closing prices of respective scrips as on May 17, 2024.
The P/E Ratio has been computed based on the closing market price of equity shares on May 17, 2024, divided by the diluted EPS.
RoNW is computed as net profit after tax attributable to equity shareholders divided by Net Worth as at March 31, 2023.
NAV is computed as the closing Net Worth divided by the closing outstanding number of equity shares.

Strength

Kronox Lab Sciences Limited offers a diverse product range of over 185 High Purity Speciality Fine Chemicals, consistently selling 156 to 188 products annually, indicating product demand.

The company maintains strong customer retention, with 111 repeat clients representing 16.74% of total customers, demonstrating reliability and customer satisfaction over consecutive fiscal periods.

Extensive R&D focus led by a Chairman with over 30 years of experience, supported by 16 specialised personnel in their RDT Laboratory, underpins innovation and high-quality product development.

Weakness

Kronox Lab Sciences faces risks if their products deviate from prescribed standards like IP, BP, EP, JP, USP, potentially leading to customer rejection and harming their reputation.

The company's growth strategy relies on a new manufacturing facility; failure to execute this could affect their business prospects and financial stability.

With top 20 products generating over 60% of revenue, a demand drop in these could significantly impact Kronox's financial results and cash flow stability.

Contact Details

Kronox Lab Sciences Limited

Block No. 353, Village Ekalbara, Padra, Vadodara-391440

+91 26 6224 4077/88

cs@kronoxlabsciences.com

https://www.kronoxlabsciences.com/

Registrar Contact Details

Kfin Technologies Limited

04067162222, 04079611000

klsl.ipo@kfintech.com

https://kosmic.kfintech.com/ipostatus/

Kronox Lab Sciences Limited IPO - FAQs

Ans. Kronox Lab Sciences Limited IPO is a Mainboard IPO. The issue is priced at ₹129-136 per equity share. The minimum order quantity is 110 Shares. The IPO opens on Jun 3, 2024, and closes on Jun 5, 2024. Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Ans. The Kronox Lab Sciences Limited IPO opens on Jun 3, 2024 and closes on Jun 5, 2024.

Ans. You can track the real-time subscription numbers using the links below:

Ans. The size of Kronox Lab Sciences Limited IPO is Offer for Sale : 9,570,000 shares(aggregating up to ₹130.15 Cr).

Ans. The Kronox Lab Sciences Limited IPO price band is set between ₹129-136 per equity share.

Ans. To apply for Kronox Lab Sciences Limited IPO, follow the steps given below:

- Open the IPO Ji App or Website
- Find Kronox Lab Sciences Limited IPO in the List of IPOs
- Press Apply Button
- Select Your Demat Account
- Select Your Shares Quantity and Submit
- Track Your IPO Status

Ans. The share allotment date of Kronox Lab Sciences Limited IPO is Jun 6, 2024.

Ans. The Kronox Lab Sciences Limited IPO will be listed on Jun 10, 2024.

Ans. Follow the steps to check the Kronox Lab Sciences Limited IPO allotment status online.